Clinical Trial Update: Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mesenchymal stem cell therapy for airway remodeling in mustard gas-exposed patients. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Pulmonary Disease

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Dr. Mostafa Ghanei | Conditions: Pulmonary Disease | Phase 1 | Status: UNKNOWN